Applied DNA Sciences (NASDAQ:APDN ) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55332	Articles
62460	Press releases

Home
Companies
Applied DNA Sciences

BRIEF

published on 10/30/2024 at 12:20, 22 days 1 hour ago

Applied DNA Sciences Raises $6.5 Million Through Direct Offering and Private Placement

Private Placement DNA Technologies Direct Offering Series C And D Warrants Craig-Hallum
PRESS RELEASE

published on 10/30/2024 at 12:15, 22 days 1 hour ago

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
Applied DNA Sciences, Inc. announces the pricing of a $6.5 million registered direct offering and concurrent private placement to develop Therapeutic DNA Production Services

Private Placement Registered Direct Offering Applied DNA Sciences DNA Technologies Therapeutic DNA Production Services
BRIEF

published on 10/15/2024 at 16:35, 1 month 5 days ago

Applied DNA to Participate in Maxim Healthcare Virtual Summit 2024

Biotechnology Applied DNA Maxim Healthcare Summit PCR DNA Technologies James A. Hayward
PRESS RELEASE

published on 10/15/2024 at 16:30, 1 month 5 days ago

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
Applied DNA Sciences to participate in Maxim Healthcare Virtual Summit with CEO Dr. James A. Hayward in a fireside chat on October 16, 2024. Company overview and business focus detailed

Biotechnology Company Applied DNA Sciences PCR-based DNA Technologies Maxim Healthcare Virtual Summit CEO Interview
BRIEF

published on 09/18/2024 at 15:05, 2 months 2 days ago

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Nasdaq Compliance Stock Market Bid Price Applied DNA PCR-based Technologies
PRESS RELEASE

published on 09/18/2024 at 15:00, 2 months 2 days ago

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Applied DNA Sciences, Inc. regains compliance with Nasdaq minimum bid price requirement. Full details on the company's PCR-based DNA technologies and markets

Biotechnology Forward-looking Statements Nasdaq Compliance Applied DNA Sciences PCR-based DNA
BRIEF

published on 09/17/2024 at 15:20, 2 months 3 days ago

Applied DNA Presents Linea IVT Platform at mRNA Summit

Applied DNA Sciences Linea IVT Platform MRNA Summit Kudo Biotechnology DsRNA Mitigation
PRESS RELEASE

published on 09/17/2024 at 15:15, 2 months 3 days ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit
Applied DNA Sciences to showcase Linea IVT platform for rapid mRNA manufacturing at mRNA events in Boston. Co-hosts seminar with Kudo Bio to demonstrate capabilities

Applied DNA Sciences Linea IVT Platform MRNA Manufacturing Kudo Bio MRNA Events
BRIEF

published on 09/17/2024 at 15:05, 2 months 3 days ago

Applied DNA Secures Significant Follow-on Order from IVD Manufacturer

Cancer Diagnostics Linea DNA PCR Technology Applied DNA IVD
PRESS RELEASE

published on 09/17/2024 at 15:00, 2 months 3 days ago

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application
Applied DNA Sciences receives a follow-on order for Linea DNA from a global IVD manufacturer valued at over $500,000, reflecting customer commitment and recurring orders. Dr. James A. Hayward optimistic about meeting growing industry needs

Applied DNA Sciences Linea DNA IVD Manufacturer Recurring Order Diagnostic Industry

Accesswire

Published on 11/21/2024 at 13:30, 18 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 18 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 48 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 48 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 48 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 32 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 12 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 33 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 41 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 48 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 50 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 28 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 3 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 3 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE